Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HBV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00128544
What this trial is testing

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B
Novartis 130
Testing effectiveness (Phase 2)UnknownNCT00225537
What this trial is testing

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
MTmedical Institute of Health 160
Post-approval studies (Phase 4)UnknownNCT02463019
What this trial is testing

Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BAntiviral Treatment
E-DA Hospital 160
Large-scale testing (Phase 3)Study completedNCT00412529
What this trial is testing

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
Novartis Pharmaceuticals 44
Not applicableStudy completedNCT02791386
What this trial is testing

Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy

Who this might be right for
Hepatitis B
Bristol-Myers Squibb 383
Very early researchNot Yet RecruitingNCT06745973
What this trial is testing

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Epigenic Therapeutics, Inc 20
Not applicableStudy completedNCT01013272
What this trial is testing

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Who this might be right for
Hepatitis B, Chronic
The University of Hong Kong 50
Post-approval studies (Phase 4)Study completedNCT01732367
What this trial is testing

TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA

Who this might be right for
Chronic Hepatitis B
Keimyung University Dongsan Medical Center 171
Testing effectiveness (Phase 2)Ended earlyNCT05760781
What this trial is testing

To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
Staidson (Beijing) Biopharmaceuticals Co., Ltd 9
Not applicableUnknownNCT02510963
What this trial is testing

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

Who this might be right for
Hepatitis B, Chronic
First Affiliated Hospital Xi'an Jiaotong University 300
Not applicableUnknownNCT01464281
What this trial is testing

Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml

Who this might be right for
Chronic Hepatitis B
The Second Affiliated Hospital of Chongqing Medical University 300
Testing effectiveness (Phase 2)Ended earlyNCT02065336
What this trial is testing

Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Arrowhead Pharmaceuticals 58
Early research (Phase 1)Study completedNCT06311734
What this trial is testing

LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Shanghai Longwood Biopharmaceuticals Co., Ltd. 119
Post-approval studies (Phase 4)Study completedNCT00614471
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 219
Not applicableUnknownNCT04301908
What this trial is testing

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis

Who this might be right for
Chronic Hepatitis b
Beijing Ditan Hospital 10,000
Post-approval studies (Phase 4)Study completedNCT01337791
What this trial is testing

Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels

Who this might be right for
Chronic Hepatitis BPregnancy ComplicationsHigh Viral Load+1 more
Southeast University, China 88
Not applicableStudy completedNCT02069678
What this trial is testing

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 82
Not applicableStudy completedNCT02511743
What this trial is testing

Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Peking University First Hospital 2,871
Post-approval studies (Phase 4)Study completedNCT03468907
What this trial is testing

The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation

Who this might be right for
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University 111
Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Next Page